Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open‐Label Trial
Yi Li(Sichuan University), Xuezhong Yu(Beijing Union University), Shuming Pan(XinHua Hospital), Haibo Qiu(Zhongda Hospital Southeast University), Zhigang Shan(PLA 306 Hospital), Joseph Harold Walline(Chinese University of Hong Kong), Peihong Lin(Fujian Medical University), Xinchao Zhang(Shandong University), Yu Cao(Sichuan University), Jie Wei(Anhui Medical University), Chuanyun Qian(First Affiliated Hospital of Kunming Medical University)
Cited by 30
Related Papers
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
|Intensive Care Medicine|2023|257
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study
|Mediators of Inflammation|2016|228
XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial
|Critical Care Medicine|2019|164
USF2 knockdown downregulates THBS1 to inhibit the TGF-β signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury
|Pharmacological Research|2021|139
Relationship between thyroid function and ICU mortality: a prospective observation study
|Critical Care|2012|138